IL1R1 and Crohn disease: Our data showing a relationship between SMAD7 and IL-1R1 expression in PSCs is also consistent with recent data demonstrating decreased inflammation and clinical benefits for patients with active Crohn’s disease after blocking SMAD7 by a SMAD7 anti-sense oligonucleotide [54].